← Back to Search

Other

Home-Based FES Training for Stroke (HomeFES Trial)

N/A
Recruiting
Led By Tanvi Bhatt, PhD
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline (week 1), mid-training (week 7) and immediate post-training (week 12)
Awards & highlights

HomeFES Trial Summary

This trial will examine the feasibility, safety, & effect of home-based FES & task-specific training in adults with chronic stroke on gait, balance & mobility.

Who is the study for?
This trial is for adults aged 18-90 with chronic stroke who can walk at least 300 ft independently and use a smartphone daily. They must have had their stroke over 6 months ago, speak English, and have internet at home. Excluded are those with recent major surgery or hospitalization, severe depression, certain medical conditions like uncontrolled hypertension or epilepsy, pacemaker users, osteoporosis, cognitive impairment or other neurological conditions.Check my eligibility
What is being tested?
The study tests the safety and effectiveness of using functional electrical stimulation (FES) at home to improve walking, balance and mobility in people with chronic stroke. Participants will receive FES devices for a 12-week training program including initial lab sessions followed by home-based exercises.See study design
What are the potential side effects?
Potential side effects may include discomfort or skin irritation where the FES device attaches to the body. There's also a risk of muscle fatigue from exercise training. The trial excludes individuals likely to experience more serious side effects.

HomeFES Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline (week 1), mid-training (week 7) and immediate post-training (week 12)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline (week 1), mid-training (week 7) and immediate post-training (week 12) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Dynamic balance from baseline to mid and post-training
Change in Functional balance from baseline to mid and post-training
Change in balance confidence from baseline to mid and post-training
+24 more

HomeFES Trial Design

1Treatment groups
Experimental Treatment
Group I: Home-training with functional electrical stimulationExperimental Treatment1 Intervention
This study employs a single group pre-post design to determine the feasibility, safety and efficacy of a 12-week of home-based combined FES and task-specific training program. Also, this study will test the effect of the same intervention on gait, mobility and balance in adults with chronic stroke.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Functional Electrical Stimulation
2007
N/A
~260

Find a Location

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
607 Previous Clinical Trials
1,559,326 Total Patients Enrolled
18 Trials studying Stroke
2,222 Patients Enrolled for Stroke
Tanvi Bhatt, PhDPrincipal InvestigatorUniversity of Illinois at Chicago
5 Previous Clinical Trials
558 Total Patients Enrolled
2 Trials studying Stroke
110 Patients Enrolled for Stroke

Media Library

Home-based FES Training (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05849532 — N/A
Stroke Research Study Groups: Home-training with functional electrical stimulation
Stroke Clinical Trial 2023: Home-based FES Training Highlights & Side Effects. Trial Name: NCT05849532 — N/A
Home-based FES Training (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05849532 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is the age eligibility for this clinical trial limited to adults, or are minors allowed to participate as well?

"This trial is inviting participation from individuals aged 18 and above who are under 90 years old."

Answered by AI

Who is eligible to partake in this medical experiment?

"Qualified applicants must have experienced a stroke and be between 18-90 years of age in order to enroll in this trial. The medical team requires 30 participants overall."

Answered by AI

Is there additional capacity for volunteers to join this medical trial?

"Indeed, the information available on clinicaltrials.gov indicates that this trial is currently recruiting participants. The posting was initiated on December 10th 2022 and most recently updated on April 27th 2023, seeking 30 patients from one medical centre."

Answered by AI

How many volunteers are participating in this medical experiment?

"Affirmative. Online records highlight that this clinical trial is still open to recruitment, having been first posted on December 10th 2022 and recently updated on April 27th 2023. It requires 30 participants across a single site."

Answered by AI
~13 spots leftby Apr 2025